e-learning
resources
Paris 2018
Monday, 17.09.2018
Pneumonia: from the community to the intensive care unit
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of Oral Chlorhexidine in Preventing Hospital-Acquired Pneumonia among non-intubated patients in the Philippines
m. ogbac (Makati, Philippines), J. Arquiza (Makati, Philippines)
Source:
International Congress 2018 – Pneumonia: from the community to the intensive care unit
Session:
Pneumonia: from the community to the intensive care unit
Session type:
Thematic Poster
Number:
2641
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
m. ogbac (Makati, Philippines), J. Arquiza (Makati, Philippines). Effect of Oral Chlorhexidine in Preventing Hospital-Acquired Pneumonia among non-intubated patients in the Philippines. 2641
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Clinical Efficacy and Cost-Effectiveness Analysis of Cefepime or Piperacillin/tazobactam both with Ciprofloxacin in MICU Patients with Severe Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Inhaled steroids in patients admitted to hospital with pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes.
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Patterns of antibiotic prescribing for pneumonia at the outpatient to inpatient transition
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Clinical Features Associated with Linezolid Resistance Among Multidrug Resistant Tuberculosis Patients at a Tertiary Care Hospital in Mumbai, India
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Hypoxemia as a determinant of hospitalization in patients with Community Acquired Pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Outcomes of Critically ill Very old patients with Acute Respiratory Distress Syndrome and Community-Acquired Pneumonia
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Evaluation of EFL Incidence and Impacts of Novel NIV Home Therapy
Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Year: 2020
Viral Sepsis in Adults with Community-Acquired Pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Prescribing Trends of Oral Corticosteroids Among Young Adults with Active Asthma
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept